Notice is hereby given that the Office of Research Integrity (ORI) has made a final finding of scientific misconduct in the following case: Ms. Maria Diaz, Rush-Presbyterian-St. Luke\'s Medical Center: Based on the report of the Rush-Presbyterian-St. Luke\'s Medical Center (RPMC) Research Integrity Investigation Committee dated May 13, 1998, which included a report of a special National Cancer Institute (NCI) audit, and additional information obtained by ORI during its oversight review, ORI finds that Ms. Diaz, former data manager for two multicenter cancer prevention clinical trials at RPMC, engaged in scientific misconduct in this clinical research supported by NCI, National Institutes of Health (NIH), cooperative agreements. Specifically, Ms. Diaz intentionally fabricated and/or falsified research data and information collected at RPMC for the Breast Cancer Prevention Trial (BCPT) under the National Surgical Adjuvant Breast and Bowel Project (NSABP) and a secondary prevention trial for lung cancer sponsored by the M.D. Anderson Cancer Center and Eastern Cooperative Oncology Group (ECOG). Ms. Diaz falsified data related to entry criteria and treatment compliance on the secondary lung cancer prevention trial. She fabricated reports of follow-up examinations for subjects entered on the BCPT, falsified laboratory test results, and forged signatures of physicians on informed consent documents. ORI has implemented the following administrative actions for the three (3) year period beginning March 13, 1999: (1) Ms. Diaz is prohibited from serving in any advisory capacity to PHS, including but not limited to service on any PHS advisory committee, board, and/or peer review committee, or as a consultant; and (2) Any institution that submits an application for PHS support for a research project on which Ms. Diaz\'s participation is proposed or which uses her in any capacity on PHS supported research, or that submits a report of PHS-funded research in which she is involved, must concurrently submit a plan for supervision of her duties to the funding agency for approval. The supervisory plan must be designed to ensure the scientific integrity of Ms. Diaz\'s research contribution. The institution also must submit a copy of the supervisory plan to ORI.
